Advertisement

Picture [iito] Made Without Love 650x80px
Document › Details

Uniqure N.V.. (8/8/18). "Press Release: Uniqure Announces Second Quarter 2018 Financial Results and Highlights Company Progress". Lexington, MA & Amsterdam.

Organisation Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
Products Product etranacogene dezaparvovec (AMT-061)
  Product 2 AMT-130 (Huntington’s disease gene therapy, Uniqure)
Persons Person Kapusta, Matthew (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew Orthopaedics)
  Person 2 Gut, Robert (Uniqure 201808– CMO before Versartis Inc + Novo Nordisk Inc)
     


   
Record changed: 2018-08-11

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Uniqure (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top